BRD4 is reported to support cell proliferation in multiple cancer types, and analysis of Dependency Map (Broad Institute) data identified that reducing BRD4 levels, by shRNA knockdown or CRISPR knockout, inhibits the proliferation of Ewing sarcoma and other cancer cell lines (Fig. 5F). Here, BRD4 is linked to cancer.